Our understanding of how cells become cancerous and invade other organs has improved significantly in recent decades. Researchers now have unprecedented access to the genomic, epigenomic and proteomic landscape of cancer cells, allowing identification of cancer characteristics which can be used to improve cancer therapy in clinical practice.